Did you read the announcement?
The master services agreement has been entered into with a significant multinational enterprise as an overarching agreement which has potential to expand across multiple projects throughout the Asia. The initial agreed project involves revenue pursuant to Yojee’s SaaS Pricing Model including the setup, subscription, professional service, and transaction fees applicable. Refer to ASX release lodged on 17 October 2018, “YOJ – Investor Presentation October 2018” which stipulates the Yojee pricing model. In Yojee’s view, the impact of the master services agreement is not financially material due to the variability and difficulty in estimating transaction volumes and project scopes. At this stage there is one project commencing with further potential projects to follow. The Company will provide market updates on projects as applicable
- Forums
- ASX - By Stock
- Ann: 3 Year SaaS Agreement Signed with Global Leader
YOJ
yojee limited
Add to My Watchlist
2.63%
!
37.0¢

o_O Did you read the announcement? The master services agreement...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $119.6M |
Open | High | Low | Value | Volume |
39.0¢ | 39.0¢ | 37.0¢ | $270.0K | 725.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 39736 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 10579 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 39736 | 0.370 |
1 | 26500 | 0.365 |
6 | 12350 | 0.360 |
5 | 32329 | 0.350 |
2 | 26000 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 10579 | 1 |
0.380 | 11700 | 1 |
0.395 | 33808 | 1 |
0.400 | 139294 | 5 |
0.430 | 2000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
YOJ (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online